 |
PDBsum entry 4ckj
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transferase
|
 |
|
Title:
|
 |
Crystal structure of ret tyrosine kinase domain bound to adenosine
|
|
Structure:
|
 |
Proto-oncogene tyrosine-protein kinase receptor ret. Chain: a. Fragment: residues 705-1013. Synonym: cadherin family member 12, proto-oncogenE C-ret. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Expressed in: spodoptera frugiperda. Expression_system_taxid: 7108.
|
|
Resolution:
|
 |
|
1.65Å
|
R-factor:
|
0.155
|
R-free:
|
0.181
|
|
|
Authors:
|
 |
I.Plaza-Menacho,K.Barnouin,K.Goodman,R.J.Martinez-Torres,A.Borg, J.Murray-Rust,S.Mouilleron,P.Knowles,N.Q.Mcdonald
|
|
Key ref:
|
 |
I.Plaza-Menacho
et al.
(2014).
Oncogenic RET kinase domain mutations perturb the autophosphorylation trajectory by enhancing substrate presentation in trans.
Mol Cell,
53,
738-751.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
06-Jan-14
|
Release date:
|
05-Mar-14
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P07949
(RET_HUMAN) -
Proto-oncogene tyrosine-protein kinase receptor Ret from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
1114 a.a.
293 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 5 residue positions (black
crosses)
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.7.10.1
- receptor protein-tyrosine kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] + ADP + H+
|
 |
 |
 |
 |
 |
L-tyrosyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-tyrosyl-[protein]
Bound ligand (Het Group name = )
matches with 70.37% similarity
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Mol Cell
53:738-751
(2014)
|
|
PubMed id:
|
|
|
|
|
| |
|
Oncogenic RET kinase domain mutations perturb the autophosphorylation trajectory by enhancing substrate presentation in trans.
|
|
I.Plaza-Menacho,
K.Barnouin,
K.Goodman,
R.J.Martínez-Torres,
A.Borg,
J.Murray-Rust,
S.Mouilleron,
P.Knowles,
N.Q.McDonald.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
To decipher the molecular basis for RET kinase activation and oncogenic
deregulation, we defined the temporal sequence of RET autophosphorylation by
label-free quantitative mass spectrometry. Early autophosphorylation sites map
to regions flanking the kinase domain core, while sites within the activation
loop only form at later time points. Comparison with oncogenic RET kinase
revealed that late autophosphorylation sites become phosphorylated much earlier
than wild-type RET, which is due to a combination of an enhanced enzymatic
activity, increased ATP affinity, and surprisingly, by providing a better
intermolecular substrate. Structural analysis of oncogenic M918T and wild-type
RET kinase domains reveal a cis-inhibitory mechanism involving
tethering contacts between the glycine-rich loop, activation loop, and
αC-helix. Tether mutations only affected substrate presentation but perturbed
the autophosphorylation trajectory similar to oncogenic mutations. This study
reveals an unappreciated role for oncogenic RET kinase mutations in promoting
intermolecular autophosphorylation by enhancing substrate presentation.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |